CSL Limited (ASX: CSL)
A note out of UBS reveals that its analysts have retained their buy rating and $346.00 price target on this biotherapeutics giant’s shares. According to the note, the broker’s research shows that CSL has opened 21 new plasma collection centres since the start of the financial year. It believes this will help mitigate some of the plasma collection headwinds it is facing because of the pandemic. And while UBS still expects plasma collections to fall meaningfully, it remains positive on the company and appears to expect other areas of the business to pick up the slack
- Forums
- ASX - By Stock
- CSL
- UBS retained buy rate for CSL
UBS retained buy rate for CSL
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$285.86 |
Change
-3.140(1.09%) |
Mkt cap ! $137.9B |
Open | High | Low | Value | Volume |
$285.27 | $286.66 | $284.20 | $69.92M | 245.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 22 | $285.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$285.94 | 94 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 197 | 285.610 |
6 | 66 | 285.600 |
5 | 154 | 285.590 |
2 | 15 | 285.580 |
7 | 116 | 285.570 |
Price($) | Vol. | No. |
---|---|---|
285.750 | 21 | 3 |
285.760 | 14 | 3 |
285.770 | 31 | 2 |
285.780 | 6 | 1 |
285.790 | 25 | 1 |
Last trade - 14.11pm 11/06/2024 (20 minute delay) ? |
|
|||||
Last
$285.76 |
  |
Change
-3.140 ( 1.09 %) |
|||
Open | High | Low | Volume | ||
$285.73 | $286.53 | $284.28 | 11261 | ||
Last updated 14.31pm 11/06/2024 ? |
Featured News
CSL (ASX) Chart |